Ander Astobieta

1.6k total citations
14 papers, 1.2k citations indexed

About

Ander Astobieta is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ander Astobieta has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Ander Astobieta's work include Bladder and Urothelial Cancer Treatments (8 papers), Urinary and Genital Oncology Studies (6 papers) and Colorectal Cancer Screening and Detection (4 papers). Ander Astobieta is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Urinary and Genital Oncology Studies (6 papers) and Colorectal Cancer Screening and Detection (4 papers). Ander Astobieta collaborates with scholars based in Spain, Italy and United States. Ander Astobieta's co-authors include Luis Martínez‐Piñeiro, Rosário Madero, Eduardo Solsona, Mariano Rabadán, Santiago Isorna, C Pertusa, J A Martínez-Piñeiro, José Emilio Camacho, Manuel Sierra Montesinos and Jesús Rodríguez-Molina and has published in prestigious journals such as The Journal of Urology, European Urology and British Journal of Clinical Pharmacology.

In The Last Decade

Ander Astobieta

13 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ander Astobieta Spain 7 949 329 279 183 149 14 1.2k
F. Millán‐Rodríguez Spain 14 770 0.8× 313 1.0× 251 0.9× 126 0.7× 57 0.4× 18 1.0k
J. Leißner Germany 15 1.1k 1.2× 570 1.7× 239 0.9× 196 1.1× 75 0.5× 36 1.3k
Piotr Chłosta Poland 14 355 0.4× 131 0.4× 395 1.4× 109 0.6× 69 0.5× 65 779
Félix Guerrero‐Ramos Spain 14 471 0.5× 133 0.4× 129 0.5× 139 0.8× 25 0.2× 91 717
Justin T. Matulay United States 16 598 0.6× 198 0.6× 222 0.8× 107 0.6× 15 0.1× 62 773
Claudio Milani Italy 8 493 0.5× 227 0.7× 82 0.3× 86 0.5× 59 0.4× 10 582
J.J. Patard France 9 240 0.3× 113 0.3× 330 1.2× 57 0.3× 35 0.2× 25 575
J A Martínez-Piñeiro Spain 15 1.6k 1.6× 584 1.8× 256 0.9× 271 1.5× 16 0.1× 51 1.7k
M. González Martín Spain 9 354 0.4× 124 0.4× 104 0.4× 117 0.6× 15 0.1× 60 484
Ž. Popov North Macedonia 15 439 0.5× 88 0.3× 155 0.6× 107 0.6× 11 0.1× 63 694

Countries citing papers authored by Ander Astobieta

Since Specialization
Citations

This map shows the geographic impact of Ander Astobieta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ander Astobieta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ander Astobieta more than expected).

Fields of papers citing papers by Ander Astobieta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ander Astobieta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ander Astobieta. The network helps show where Ander Astobieta may publish in the future.

Co-authorship network of co-authors of Ander Astobieta

This figure shows the co-authorship network connecting the top 25 collaborators of Ander Astobieta. A scholar is included among the top collaborators of Ander Astobieta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ander Astobieta. Ander Astobieta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lughezzani, Giovanni, Hannes Cash, Laura Wiemer, et al.. (2020). MP81-10 RISK STRATIFICATION FOR EQUIVOCAL PI-RADS 3 RESULTS: CAN MICRO-ULTRASOUND HELP DETERMINE WHICH MEN TO BIOPSY?. The Journal of Urology. 203(Supplement 4). 1 indexed citations
2.
Lughezzani, Giovanni, et al.. (2018). Comparison of Micro-Ultrasound and Multiparametric MRI Imaging for Prostate Cancer: An International Meta-Analysis. European Urology Supplements. 17(13). e2766–e2766. 1 indexed citations
3.
4.
Astobieta, Ander, et al.. (2012). [Salvage high energy focalized ultrasound (HIFU) in prostate cancer after radiotherapy].. PubMed. 65(1). 101–10. 1 indexed citations
5.
6.
Gómez, J.M. Fernández, Rosário Madero, E. Solsona, et al.. (2011). The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables. International braz j urol. 37(5). 671–672. 8 indexed citations
7.
Gómez, J.M. Fernández, Rosário Madero, Eduardo Solsona, et al.. (2009). Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model. The Journal of Urology. 182(5). 2195–2203. 443 indexed citations
8.
Gómez, J.M. Fernández, Eduardo Solsona, Miguel Unda, et al.. (2007). Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials. European Urology. 53(5). 992–1002. 194 indexed citations
9.
Ibarluzea, Jesús, Cesare Marco Scoffone, Cecilia Cracco, et al.. (2007). Supine Valdivia and modified lithotomy position for simultaneous anterograde and retrograde endourological access. British Journal of Urology. 100(1). 233–236. 178 indexed citations
10.
Ibarluzea, Jesús, et al.. (2006). PERCUTANEOUS NEPHROLITHOTOMY IN THE SUPINE POSITION. European Urology Supplements. 5(2). 110–110.
11.
Martínez-Piñeiro, J A, Luis Martínez‐Piñeiro, Eduardo Solsona, et al.. (2005). HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL. The Journal of Urology. 174(4 Part 1). 1242–1247. 139 indexed citations
12.
Jauregizar, Nerea, et al.. (2003). Population pharmacokinetics of netilmicin in short‐term prophylactic treatment. British Journal of Clinical Pharmacology. 55(6). 552–559. 6 indexed citations
13.
Solsona, E., Rafael Rodríguez, Jesús Rodríguez Molina, et al.. (2003). Comparison of a standard BCG dose (81 MG) versus a three-fold reduced dose (27 MG) in high risk superficial bladder cancer (TIG3, TIS), A cueto prospective randomised study #95012. European Urology Supplements. 2(1). 190–190. 3 indexed citations
14.
Astobieta, Ander, et al.. (1993). Netilmicin kinetics in urology.. PubMed. 31(11). 557–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Millán‐Rodríguez Breakdown of academic impact, for papers by J. Leißner Breakdown of academic impact, for papers by Piotr Chłosta Breakdown of academic impact, for papers by Félix Guerrero‐Ramos Breakdown of academic impact, for papers by Justin T. Matulay Breakdown of academic impact, for papers by Claudio Milani Breakdown of academic impact, for papers by J.J. Patard Breakdown of academic impact, for papers by J A Martínez-Piñeiro Breakdown of academic impact, for papers by M. González Martín Breakdown of academic impact, for papers by Ž. Popov
Rankless by CCL
2026